Rl. Stickle et al., Prevention of irradiation-induced esophagitis by plasmid/liposome deliveryof the human manganese superoxide dismutase transgene, RADIAT ON I, 7(4), 1999, pp. 204-217
Esophagitis is a major toxicity of radiation therapy for nonsmall-cell lung
cancer. Intraesophageal injection of manganese superoxide dismutase (MnSOD
) plasmid/liposome complexes (1 mg of the pRK5-MnSOD plasmid containing the
human MnSOD transgene in a 0.15 ml volume of lipofectin) before irradiatio
n was carried out to attempt to prevent irradiation esophagitis. In control
noninjected male C3H/HeNsd mice, esophagitis was induced by single fractio
n 3,500 cGy irradiation. Histopathology at 4 days revealed vacuole formatio
n in squamous lining cells, separation of the squamous layer from the under
lying muscle layer, ulceration at 7 days, and dehydration and death by 30 d
ays. MnSOD plasmid/liposome complex-injected mice showed transcription of t
he human MnSOD transgene message in esophageal squamous lining cells by nes
ted reverse transcriptase-polymerase chain reaction (RT-PCR) increased MnSO
D biochemical activity 24 h after injection, decreased vacuole formation at
day 4 (P < 0.001) after 3,500 cGy thoracic irradiation, and improved survi
val (P = 0.0009). In contrast, groups of mice receiving LacZ (bacterial bet
a-galactosidase gene) plasmid/liposome complexes or liposomes containing no
DNA before 3,500 cGy irradiation showed an unaltered irradiation histopath
ology and decreased survival. Mice receiving intraesophageal MnSOD plasmid/
Liposomes followed 8 h later by human equivalent doses of Taxol (1.4 mg/kg
) and carboplatin (2.5 mg/kg), then 15 h later 3,300 cGy irradiation, showe
d increased survival, compared with irradiated control or LacZ plasmid/lipo
some groups. Thus, overexpression of the human MnSOD transgene in the esoph
agus can prevent irradiation-induced esophagitis in the mouse model. Radiat
. Oncol. Invest. 7:204-217, 1999. (C) 1999 Wiley-Liss, Inc.